Apnea in the newborn

Indian Journal of Pediatrics

Volumn 75, Issue 1, 2008, Pages 57-61

  Mishra, Satish ^a   Agarwal, Ramesh ^a   Jeevasankar, M ^a   Aggarwal, Rajiv ^b   Deorari, Ashok K ^a   Paul, Vinod K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Narayana Hridalaya   (India)

Author keywords

Apnea; Methylxanthines

Indexed keywords

AMINOPHYLLINE; BENZYL ALCOHOL; CAFFEINE; CAFFEINE CITRATE; DOXAPRAM; METHYLXANTHINE; THEOPHYLLINE; XANTHINE; BRONCHODILATING AGENT; CENTRAL STIMULANT AGENT;

ABDOMINAL DISTENSION; ARTIFICIAL VENTILATION; BAROTRAUMA; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG HALF LIFE; DRUG MECHANISM; EMERGENCY CARE; FEEDING DISORDER; HUMAN; HYPERACTIVITY; HYPERGLYCEMIA; HYPERTENSION; IRRITABILITY; LOADING DRUG DOSE; MORBIDITY; NERVE CELL DIFFERENTIATION; NERVOUSNESS; NEWBORN APNEA; NEWBORN MONITORING; NOSE IRRITATION; PATHOGENESIS; PLETHYSMOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PULSE OXIMETER; RECOMMENDED DRUG DOSE; SEIZURE; SIDE EFFECT; SUDDEN INFANT DEATH SYNDROME; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; VOMITING; APNEA; DRUG COMBINATION; INDIA; METHODOLOGY; NEWBORN; PREMATURITY; REVIEW; STIMULATION;

APNEA; BRONCHODILATOR AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; HUMANS; INDIA; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PHYSICAL STIMULATION; RESPIRATION, ARTIFICIAL;

EID: 42449085896     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-008-0008-7     Document Type: Conference Paper

References (17)

1. Hunt CE. Apnea and sudden infant death syndrome. In Kligman RM, Neider ML, Super DM, eds. Practical strategiesin pediatric diagnosis and therapy. Philadelphia; WB Saunders, 1996: 135-147.
2. Bhatia J. Current options in the management of apnea of prematurity. Clin Pediatr 2000; 39: 327-336.
3. th ed. Philadelphia; Lippincott Williams and Wilkins, 1998; 539-545.
4. Martin RJ, Abu-Shaweesh, Baird TM. Pathophysiologic Mechanisms Underlying Apnea of Prematurity. Neo Reviews 2002; 3: e59.
5. Deorari AK. In Deorari AK, Paul VK, eds. Neonatal Equipment Everything that you like to know 3rd ed. New Delhi; Sagar Publication, 2006; 60-61.
6. Henderson-Smart DJ, Steer P. Methylxanthine treatment for apnea in preterm infants. Cochrane Database Syst Rev 2000.
7. Henderson-Smart DJ, Steer P. Prophylactic methylxanthine for extubation in preterm infants. Cochrane Database Syst Rev 2004.
8. Martin RJ, Abu-Shaweesh, Baird TM. Clinical Associations, Treatment, and Outcome of Apnea of Prematurity. Neo Reviews 2002; 3: e66.
9. Miller MJ, Martin RJ. Apnea of prematurity. Clin Perinatol 1992; 19: 789-808.
10. Henderson-Smart DJ, Steer PA. Prophylactic methylxanthine for prevention of apnea in preterm infants. Cochrane Database Syst Rev 2006.
11. Henderson-Smart DJ, Steer PA. Doxapram treatment for apnea in preterm infants. Cochrane Database Syst Rev 2004.
12. th ed. Philadelphia, WB Saunders, 1998; 552-561.
13. Jardine DS, Rogers K. Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in premature infants. Pediatrics; 83: 721.
14. Kumar M, Kabra NS, Paes B. Carnitine supplementation for preterm infants with recurrent apnea. Cochrane Database Syst Rev 2004.
15. Henderson-Smart DJ, Subramanian P, Davis PG. Continuous positive airway pressure versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev 2005.
16. Davis PG, Henderson-Smart DJ. Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2003.
17. Osborn DA, Henderson-Smart DJ, Kinesthetic stimulation for treating apnea in preterm infants. Cochrane Database Syst Rev 2003.